OXFORD TARGET THERAPEUTICS LIMITED
OXFORD TARGET THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 13886983, incorporated on 2 February 2022. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 4 years. Registered office address: OX3 0BP Oxford, the United Kingdom. Directors include DR VICTOR MARTIN BOLANOS-GARCIA and PROF LINDA ANNE KING. Sole shareholder is DR VICTOR MARTIN BOLANOS-GARCIA. Associated with 4 related entities, including OET LIMITED, BACULO CONSULTING LIMITED, and OXFORD EXPRESSION TECHNOLOGIES LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
BIOINNOVATION HUB, TONGE BUILDING OXFORD BROOKES UNIVERSITY
GIPSY LANE, HEADINGTON CAMPUS
OXFORDSHIRE
OX3 0BP OXFORD
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 13886983 | 2026-06-01 | open_in_new |